JBG Smith (JBGS)

NYSEReal EstateReit - DiversifiedSnapshot 2026-10-23

$11.57+1.58%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge JBG Smith’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	120.62M
EPS	—	0
Annual ending 2026-12-31
Revenue	—	479.03M
EPS	—	-1.94
Annual ending 2027-12-31
Revenue	—	487.66M
EPS	—	0

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Operating income improves toward break-even	The company aims to stabilize assets for $21.1M in annual net operating income.	Intact	Operating income falls below -$23.0M next quarter	Operating income: $8.135M FY2026-Q2; GAAP. Published target: Operating income >= -$23.0M next quarter. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Aug 10, 20268,135,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Cash from operations increases	Cash from operations is rising, showing better financial health.	Broken	Cash from operations falls below $12.9M next quarter	Cash from operations: $19.812M FY2026-Q2; GAAP. Published target: Cash from operations >= $12.9M next quarter. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Aug 10, 202619,812,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Stabilize assets for $21.1M annualized NOI	The company aims to stabilize assets for $21.1M in annual net operating income.	Intact	Annualized NOI falls below $21.1M	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	Unavailable	— / 1
2026-07-25	Unavailable	Unavailable	0 / 1
2026-07-26	Unavailable	Unavailable	— / 1
2026-07-27	Unavailable	Unavailable	0 / 1
2026-07-28	Unavailable	Unavailable	0 / 1
2026-07-29	Unavailable	Unavailable	— / 1
2026-07-30	Unavailable	Unavailable	— / 1
2026-07-31	Unavailable	Unavailable	— / 1
2026-08-01	Unavailable	Unavailable	0 / 1
2026-08-02	Unavailable	Unavailable	— / 1
2026-08-03	Unavailable	Unavailable	— / 1
2026-08-04	Unavailable	Unavailable	— / 1
2026-08-05	Unavailable	Unavailable	— / 1
2026-08-06	Unavailable	Unavailable	0 / 1
2026-08-07	Unavailable	Unavailable	0 / 1
2026-08-08	Unavailable	Unavailable	— / 1
2026-08-09	Unavailable	Unavailable	— / 1
2026-08-10	Unavailable	Unavailable	— / 1
2026-08-12	Unavailable	Unavailable	0 / 1
2026-08-13	Unavailable	Unavailable	— / 2
2026-08-14	Unavailable	Unavailable	0 / 1
2026-08-15	Unavailable	Unavailable	0 / 1
2026-08-16	Unavailable	Unavailable	0 / 1
2026-08-17	Unavailable	Unavailable	0 / 1
2026-08-18	Unavailable	Unavailable	0 / 1
2026-08-19	Unavailable	Unavailable	0 / 1
2026-08-20	Unavailable	Unavailable	0 / 2
2026-08-21	Unavailable	Unavailable	0 / 2
2026-08-22	Unavailable	Unavailable	0 / 2
2026-08-23	Unavailable	Unavailable	0 / 2
2026-08-24	Unavailable	Unavailable	0 / 2
2026-08-25	Unavailable	Unavailable	0 / 2
2026-08-26	Unavailable	Unavailable	0 / 2
2026-08-27	Unavailable	Unavailable	0 / 2
2026-08-28	Unavailable	Unavailable	0 / 2
2026-08-29	Unavailable	Unavailable	0 / 2
2026-08-30	Unavailable	Unavailable	0 / 2
2026-08-31	Unavailable	Unavailable	0 / 2
2026-09-01	Unavailable	Unavailable	0 / 2
2026-09-02	Unavailable	Unavailable	0 / 2
2026-09-03	Unavailable	Unavailable	0 / 2
2026-09-04	Unavailable	Unavailable	0 / 2
2026-09-05	Unavailable	Unavailable	0 / 2
2026-09-06	Unavailable	Unavailable	0 / 2
2026-09-07	Unavailable	Unavailable	0 / 2
2026-09-08	Unavailable	Unavailable	0 / 2
2026-09-09	Unavailable	Unavailable	0 / 2
2026-09-10	Unavailable	Unavailable	0 / 2
2026-09-11	Unavailable	Unavailable	0 / 2
2026-09-12	Unavailable	Unavailable	0 / 2
2026-09-13	Unavailable	Unavailable	0 / 2
2026-09-14	Unavailable	Unavailable	0 / 2
2026-09-15	Unavailable	Unavailable	0 / 2
2026-09-16	Unavailable	Unavailable	0 / 2
2026-09-17	Unavailable	Unavailable	0 / 2
2026-09-18	Unavailable	Unavailable	0 / 2
2026-09-19	Unavailable	Unavailable	0 / 2
2026-09-20	Unavailable	Unavailable	0 / 2
2026-09-21	Unavailable	Unavailable	0 / 2
2026-09-22	Unavailable	Unavailable	0 / 2
2026-09-23	Unavailable	Unavailable	0 / 1
2026-09-24	Unavailable	Unavailable	0 / 1
2026-09-25	Unavailable	Unavailable	0 / 1
2026-09-26	Unavailable	Unavailable	0 / 1
2026-09-27	Unavailable	Unavailable	0 / 1
2026-09-28	Unavailable	Unavailable	0 / 1
2026-09-29	Unavailable	Unavailable	0 / 1
2026-09-30	Unavailable	Unavailable	0 / 1
2026-10-01	Unavailable	Unavailable	0 / 1
2026-10-02	Unavailable	Unavailable	0 / 1
2026-10-03	Unavailable	Unavailable	0 / 1
2026-10-04	Unavailable	Unavailable	0 / 1
2026-10-05	Unavailable	Unavailable	0 / 1
2026-10-06	Unavailable	Unavailable	0 / 1
2026-10-07	Unavailable	Unavailable	0 / 1
2026-10-08	Unavailable	Unavailable	0 / 1
2026-10-09	Unavailable	Unavailable	0 / 1
2026-10-10	Unavailable	Unavailable	0 / 1
2026-10-11	Unavailable	Unavailable	0 / 1
2026-10-12	Unavailable	Unavailable	0 / 1
2026-10-13	Unavailable	Unavailable	0 / 1
2026-10-14	Unavailable	Unavailable	0 / 1
2026-10-15	Unavailable	Unavailable	0 / 1
2026-10-16	Unavailable	Unavailable	0 / 1
2026-10-17	Unavailable	Unavailable	0 / 1
2026-10-18	Unavailable	Unavailable	0 / 1
2026-10-19	Unavailable	Unavailable	0 / 1
2026-10-20	Unavailable	Unavailable	0 / 1
2026-10-21	Unavailable	Unavailable	0 / 1
2026-10-22	Unavailable	Unavailable	0 / 1
2026-10-23	Unavailable	Unavailable	0 / 1
2026-10-24	Unavailable	Unavailable	0 / 1

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Hold	Sell*
2026-05-01	1	2
2026-06-01	1	2
2026-07-01	1	2
2026-08-01	1	2
2026-09-01	1	2
2026-10-01	1	2

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 0 Buy / Strong Buy · 1 Hold · 2 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Operating income improves toward break-evenOperating income: $8.135M
Cash from operations increasesPublished status: Broken
Stabilize assets for $21.1M annualized NOIDirect metric needs a verified mapping

Next proof point

Oct 27, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.3%Typical daily move · historical

Downside history

-52.6%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

JBG Smith outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a real estate restructuring and recovery story, not a steady compounder today. The multi-year view depends on converting or redeveloping obsolete office space, bringing in private capital, and improving financial performance; current evidence leaves the thesis in a watch state.

What's priced into JBG Smith

JBGS is valued at a 29% premium to peers, while the expectations gap is negative, suggesting expectations are not especially supportive relative to the valuation. The pricing assessment calls this justified, and fragility is low, but confidence is medium and the valuation relies on re-rating rather than a clear earnings foundation.

What the fundamentals likely do

Near-term results are weak: revenue was stable around $127.6 million in the first two quarters of 2026, while operating losses narrowed in the first quarter from the prior quarter. Management has made mixed progress on joint ventures and office conversions, but company quality has recently declined and JBGS missed its latest quarter. Elevated sector headwinds and a 52% estimated miss probability keep near-term execution risk in focus.

What JBG Smith hinges on

Over the next one to three years, the thesis hinges on whether conversions, redevelopment, and joint ventures improve the portfolio and support long-term net asset value per share growth. Near term, a guidance cut would weaken the setup, while rate cuts or stronger results and guidance from real estate peers could provide sector support.